e.l.f. Beauty SVP executes 10b5-1 plan: option exercise and sale disclosed
Rhea-AI Filing Summary
Insider transaction summary for e.l.f. Beauty, Inc. (ELF): Senior Vice President and General Counsel Scott Milsten executed a planned set of transactions on 09/12/2025 under a 10b5-1 trading plan adopted June 11, 2025. He exercised 15,000 stock options at an exercise price of $26.84 per share and immediately sold 15,000 common shares in multiple trades at a weighted average sale price of $140.2843 per share. After these transactions he beneficially owned 127,406 shares (including 46,855 restricted stock units) and reported an indirect holding of 22,761 shares through the Milsten/Conner Trust dated October 17, 2008.
Positive
- Transaction executed under a 10b5-1 trading plan, providing procedural compliance and clarity about timing
- Substantial continued ownership: 127,406 shares including 46,855 restricted stock units, indicating ongoing insider stake
- Disclosure provides price range details and offers to supply per-trade quantities on request, enhancing transparency
Negative
- Sale of 15,000 shares by a senior executive on 09/12/2025, representing an insider disposition
- Immediate sale following option exercise could be viewed as dilution of insider-held options into marketable shares
Insights
TL;DR: Insider exercised options and sold shares under a pre-established 10b5-1 plan; post-transaction holdings remain material.
The execution shows a routine exercise-to-sale sequence: 15,000 options were exercised at $26.84 and the same number of shares were sold at a weighted average of $140.2843, consistent with a liquidity or diversification action rather than a one-off block sale. The filing discloses substantial continuing ownership: 127,406 shares including 46,855 RSUs, plus 22,761 shares held indirectly via trust. For investors, this is a material insider disposition but performed under a documented trading plan.
TL;DR: Transactions comply with a 10b5-1 plan and are transparently disclosed; indirect holdings and RSUs are reported.
The report specifies the 10b5-1 plan adoption date and provides customary footnote detail on sale price ranges and provision to furnish per-trade data on request, which supports procedural compliance. It also discloses an indirect trust holding and the holder's executive titles. These elements meet disclosure expectations and allow stakeholders to assess timing and intent based on documented plan parameters.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
| Exercise | Common Stock, $0.01 par value | 15,000 | $26.84 | $403K |
| Sale | Common Stock, $0.01 par value | 15,000 | $140.2843 | $2.10M |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Footnotes (1)
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. Includes 46,855 restricted stock units. The transaction was executed in multiple trades in prices ranging from $140.00 to $140.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option shall vest and become exercisable in three equal tranches on the the thirtieth consecutive trading day that the per share closing trading price of the Issuer's common stock equals or exceeds certain successively higher share price targets, subject to the Reporting Person continuing to provide services to the Issuer as an employee, consultant, director or officer of the Company through the applicable vesting date.
